Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AVPR1A | P37288 | 1/20 | 0.47 |
| ▸ | PTGDR | Q13258 | 4/20 | 0.45 |
| ▸ | PTGDR2 | Q9Y5Y4 | 4/20 | 0.45 |
| ▸ | PTGER2 | P43116 | 3/20 | 0.45 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.45 |
| ▸ | MEN1 | O00255 | 2/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.42 |
| ▸ | TP53 | P04637 | 1/20 | 0.42 |
| ▸ | TSHR | P16473 | 1/20 | 0.42 |
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
| ▸ | CASP3 | P42574 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7811489 | 0.86 | ALDH1A1 (0.45) | AVPR1APTGDRPTGDR2PTGER2CYP2C9 | |
| SCHEMBL9011127 | 0.85 | AVPR1A (0.49) | AVPR1APTGDRPTGDR2PTGER2CYP2C9 | |
| SCHEMBL9010984 | 0.84 | PTGDR (0.47) | AVPR1APTGDRPTGDR2PTGER2CYP2C9 | |
| SCHEMBL7804350 | 0.80 | AVPR1A (0.44) | AVPR1APTGDRPTGDR2PTGER2CYP2C9 | |
| SCHEMBL9011053 | 0.79 | AVPR1A (0.47) | AVPR1APTGDRPTGDR2PTGER2CYP2C9 | |
| SCHEMBL9011187 | 0.78 | PTGDR (0.45) | AVPR1APTGDRPTGDR2PTGER2CYP2C9 | |
| SCHEMBL7813359 | 0.75 | ALDH1A1 (0.47) | AVPR1APTGDRPTGDR2PTGER2CYP2C9 | |
| SCHEMBL9011033 | 0.75 | AVPR1A (0.55) | AVPR1AMEN1KMT2AALDH1A1LMNA | |
| SCHEMBL7817534 | 0.75 | PTGDR (0.43) | AVPR1APTGDRPTGDR2PTGER2CYP2C9 | |
| SCHEMBL9011192 | 0.74 | MEN1 (0.51) | AVPR1APTGDRPTGDR2PTGER2CYP2C9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5532371-A | SIDE EFFECT REDUCTION | SS PHARMACEUTICAL CO., LTD. (JP) | 1996-07-02 | — | — | US | disclosed |
| US-5411972-A | Arylamide derivatives for treating hyperlipemia | SS PHARMACEUTICAL CO., LTD. (JP) | 1995-05-02 | — | — | US | disclosed |
| EP-0607536-A1 | Arylamide derivatives | SS PHARMACEUTICAL CO., LTD. (JP) | 1994-07-27 | — | — | EP | disclosed |